CONMED financials
$46.69+0.45%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.37B | $1.31B | $1.24B | $1.05B | $1.01B | $862.5M | $955.1M | $859.6M | $796.4M | $763.5M |
| Gross profit | $750.5M | $733.0M | $676.2M | $571.2M | $568.0M | $460.3M | $524.7M | $469.1M | $431.0M | $408.3M |
| Gross margin | 54.6% | 56.1% | 54.3% | 54.6% | 56.2% | 53.4% | 54.9% | 54.6% | 54.1% | 53.5% |
| Operating income | $102.6M | $200.3M | $120.6M | $70.1M | $109.7M | $46.0M | $79.1M | $71.3M | $46.9M | $37.7M |
| Net income | $47.1M | $132.4M | $64.5M | -$80.6M | $62.5M | $9.5M | $28.6M | $40.9M | $55.5M | $14.7M |
| Net margin | 3.4% | 10.1% | 5.2% | −7.7% | 6.2% | 1.1% | 3.0% | 4.8% | 7.0% | 1.9% |
| Diluted EPS | $1.51 | $4.25 | $2.04 | $-2.68 | $1.94 | $0.32 | $0.97 | $1.41 | $1.97 | $0.52 |
| EBITDA | $176.9M | $272.2M | $192.5M | $139.6M | $180.5M | $118.6M | $151.4M | $132.1M | $104.4M | $93.0M |
| Operating cash flow | $170.7M | $167.0M | $125.3M | $33.4M | $111.8M | $64.5M | $95.1M | $74.7M | $65.6M | $39.9M |
| Free cash flow | $150.9M | $153.9M | $106.3M | $11.6M | $96.9M | $51.5M | $75.1M | $58.2M | $52.7M | $25.1M |
| Diluted shares | 31.1M | 31.2M | 31.5M | 30.0M | 32.2M | 29.5M | 29.5M | 28.9M | 28.2M | 28.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $40.8M | $24.5M | $24.3M | $28.9M | $20.8M | $27.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $834.9M | $905.8M | $973.8M | $1.05B | $684.7M | $753.6M |
| Total assets | $2.33B | $2.31B | $2.30B | $2.30B | $1.77B | $1.75B |
| Total liabilities | $1.29B | $1.34B | $1.47B | $1.55B | $980.6M | $1.04B |
| Shareholders' equity | $1.03B | $962.7M | $834.2M | $745.5M | $785.4M | $709.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology